HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suzie H Pun Selected Research

Antifibrinolytic Agents (Antifibrinolytics)

1/2016A Fibrin Cross-linking Polymer Enhances Clot Formation Similar to Factor Concentrates and Tranexamic Acid in an in vitro Model of Coagulopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Suzie H Pun Research Topics

Disease

32Neoplasms (Cancer)
03/2024 - 11/2003
8Wounds and Injuries (Trauma)
09/2023 - 11/2004
6Hemorrhage
12/2020 - 03/2015
3Lymphoma (Lymphomas)
01/2022 - 12/2012
3Spinal Cord Injuries (Spinal Cord Injury)
04/2020 - 05/2008
3Carcinoma (Carcinomatosis)
01/2018 - 09/2010
2Nervous System Diseases (Neurological Disorders)
01/2023 - 01/2016
2Hemolysis
10/2021 - 01/2019
2Cicatrix (Scar)
04/2020 - 10/2014
2Kidney Diseases (Kidney Disease)
01/2020 - 12/2018
2Neurodegenerative Diseases (Neurodegenerative Disease)
10/2019 - 03/2016
2B-Cell Lymphoma (Lymphoma, B Cell)
10/2019 - 12/2012
2Thrombosis (Thrombus)
02/2016 - 07/2015
2Vascular System Injuries
07/2015 - 03/2015
1Bites and Stings (Sting)
03/2024
1Virus Diseases (Viral Diseases)
01/2022
1T-Cell Leukemia (Leukemia, T Cell)
01/2022
1COVID-19
01/2022
1Hypersensitivity (Allergy)
10/2021
1Carcinogenesis
01/2021
1B-Cell Leukemia (Leukemia, B Cell)
01/2020
1Rupture
01/2019
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
01/2018
1Inflammation (Inflammations)
01/2018
1Breast Neoplasms (Breast Cancer)
12/2017
1Tissue Adhesions
02/2016
1Hematoma
02/2016
1Disease Progression
01/2016
1Neoplasm Metastasis (Metastasis)
01/2016
1Demyelinating Diseases (Demyelinating Disease)
10/2014
1Adenocarcinoma
02/2013
1Metaplasia
02/2013

Drug/Important Bio-Agent (IBA)

15Peptides (Polypeptides)IBA
01/2023 - 05/2015
12PolymersIBA
01/2021 - 09/2009
7MicellesIBA
01/2022 - 09/2010
7Nucleic AcidsIBA
10/2019 - 11/2003
5LigandsIBA
01/2020 - 11/2003
4AntigensIBA
01/2022 - 01/2021
4Hemostatics (Antihemorrhagics)IBA
12/2020 - 03/2015
4Chimeric Antigen ReceptorsIBA
01/2020 - 07/2015
4Proteins (Proteins, Gene)FDA Link
10/2019 - 05/2015
4polySTATIBA
01/2017 - 03/2015
3Biocompatible Materials (Biomaterials)IBA
01/2022 - 07/2015
3Transferrin Receptors (Transferrin Receptor)IBA
01/2022 - 11/2003
3Drug CarriersIBA
01/2020 - 09/2015
3EnzymesIBA
01/2018 - 07/2004
3FibrinIBA
01/2017 - 07/2015
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016 - 10/2010
2VaccinesIBA
01/2024 - 01/2023
2Melitten (Melittin)IBA
10/2021 - 10/2021
2AcidsIBA
12/2018 - 01/2018
2Monoclonal AntibodiesIBA
01/2018 - 12/2012
2Folic Acid (Vitamin M)FDA LinkGeneric
01/2016 - 09/2015
2Blood Coagulation Factors (Coagulation Factor)IBA
01/2016 - 03/2015
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2012 - 09/2010
2Transferrin (beta 2 Transferrin)IBA
07/2004 - 11/2003
2CyclodextrinsIBA
07/2004 - 11/2003
1Cathepsin BIBA
03/2024
1Valine (L-Valine)FDA Link
03/2024
1InterferonsIBA
03/2024
1Alanine (L-Alanine)FDA Link
03/2024
1Mannose (D-Mannose)IBA
03/2024
1ProdrugsIBA
03/2024
1Cancer VaccinesIBA
01/2023
1Small Interfering RNA (siRNA)IBA
01/2022
1Nucleotide AptamersIBA
01/2022
1Bee Venoms (Bee Venom)IBA
10/2021
1Platelet Activating FactorIBA
10/2021
1CV 6209IBA
10/2021
1IntegrinsIBA
01/2021
1ThrombinFDA Link
04/2020
1HydrogelsIBA
04/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2018
1SuspensionsIBA
02/2016
1ChitosanIBA
02/2016
1KLA peptideIBA
01/2016
1Antifibrinolytic Agents (Antifibrinolytics)IBA
01/2016
1AntibodiesIBA
12/2015
1VitaminsIBA
12/2015
1CollagenIBA
10/2015
1Collagenases (Collagenase)FDA Link
10/2015
1Antimicrobial Cationic PeptidesIBA
05/2015
1Heparin (Liquaemin)FDA LinkGeneric
10/2014
1GelsIBA
10/2014
1HirudinsIBA
10/2014
1Polylactic Acid-Polyglycolic Acid CopolymerIBA
10/2014
1Poloxamer (Poloxamer 407)IBA
10/2014
1Stimuli Responsive PolymersIBA
06/2013
1Cell Surface ReceptorsIBA
02/2013

Therapy/Procedure

19Therapeutics
03/2024 - 11/2003
8Immunotherapy
03/2024 - 07/2015
3Drug Therapy (Chemotherapy)
01/2018 - 10/2013
2Intravenous Administration
03/2015 - 09/2010
2Injections
10/2010 - 07/2004
1Blood Component Removal (Apheresis)
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
04/2020
1Immunomodulation
02/2016
1Resuscitation
03/2015
1Microspheres (Microsphere)
10/2014